1. Home
  2. BNR vs FMN Comparison

BNR vs FMN Comparison

Compare BNR & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$9.40

Market Cap

94.4M

Sector

Health Care

ML Signal

N/A

Logo Federated Hermes Premier Municipal Income Fund

FMN

Federated Hermes Premier Municipal Income Fund

HOLD

Current Price

$11.12

Market Cap

88.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
FMN
Founded
2014
2002
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
94.4M
88.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
FMN
Price
$9.40
$11.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.1K
28.4K
Earning Date
06-05-2026
01-01-0001
Dividend Yield
N/A
3.86%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.31
$10.41
52 Week High
$41.72
$11.76

Technical Indicators

Market Signals
Indicator
BNR
FMN
Relative Strength Index (RSI) 46.02 32.27
Support Level $8.34 $11.00
Resistance Level $10.00 $11.33
Average True Range (ATR) 0.78 0.11
MACD -0.01 -0.04
Stochastic Oscillator 17.10 6.22

Price Performance

Historical Comparison
BNR
FMN

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

Share on Social Networks: